When it comes to pinpointing the best courses of treatment for cancer patients, there is always room for improvement. That has been the belief for two investigators at the Washington University School of Medicine, leading them to the groundbreaking development of a genomic sequencing test that captures a full picture of patient-specific data. This provides crucial information that physicians can use to help determine optimal treatment strategies for individual patients with certain kinds of blood cancers...
Read the full article here.
